{
    "organizations": [],
    "uuid": "103944ded3f4f6bb4df1ca4c408330fcfc5f2ce3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-alembic-pharmaceuticals-dec/brief-indias-alembic-pharmaceuticals-dec-qtr-consol-pat-rises-idUSFWN1PQ08X",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Alembic Pharmaceuticals Dec Qtr Consol PAT Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Indiaâ€™s Alembic Pharmaceuticals Ltd :\n* DEC QUARTER CONSOL NET PAT 1.31 BILLION RUPEES VERSUS 843.9 MILLION RUPEES YEAR AGO\n* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 8.40 BILLION RUPEES VERSUS 7.77 BILLION RUPEES YEAR AGO Source text - bit.ly/2rU1GCl Further company coverage:\n ",
    "published": "2018-01-31T14:44:00.000+02:00",
    "crawled": "2018-02-01T14:59:52.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "india",
        "alembic",
        "pharmaceutical",
        "ltd",
        "dec",
        "quarter",
        "consol",
        "net",
        "pat",
        "billion",
        "rupee",
        "versus",
        "million",
        "rupee",
        "year",
        "ago",
        "dec",
        "quarter",
        "consol",
        "revenue",
        "operation",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "year",
        "ago",
        "source",
        "text",
        "company",
        "coverage"
    ]
}